TalkMed Group, which specialises in cancer treatment, says that officials from the Ministry of Health "visited" three of its clinics concurrently on Aug 21, where the company's haematologists are "practising", to "find out" about the use of chimeric antigen receptors (CAR) T-cell therapy.

According to TalkMed, the health officials were attended by its nursing managers, operations executives and clinical research coordinator "who suggested for them to write in officially so that we could respond to their further queries in writing."

TalkMed, in its SGX filing on Aug 29, says that through its subsidiary, BioCell Innovations, it is now able to produce humanised CD-19 CAR, a form of cellular therapy for lymphoma and leukemia.

"We have yet to deploy it at the clinics. We plan to apply for its use when we have eligible patients," adds TalkMed.

TalkMed shares ended Aug 29 at 39 cents, down 2.5%.

Health officials 'visited' three of TalkMed's clinics concurrently to 'find out' use of cellular treatment

MSCI boss warns of climate risks

Keppel to acquire 50% stake in European asset manager Aermont Capital for up to $517 mil

Local banks 'resilient' in 2023, but MAS warns of deteriorating asset quality, climate transition risks

The new kings and queens of content

Singapore’s headline and core inflation figures increase to 4.7% and 3.3% in October

UOB Kay Hian lowers MPACT’s TP, DPU on lower contributions from China and further depreciation on forex

Matter of time before Straits Times Index stages rally

About 62.5% of shares in VTAC have been redeemed prior to the despac

The cybersecurity parasite hiding in plain sight

Why hyperscaler investments don't equate to cloud success for SEA

How AWS empowers Asean organisations to innovate with generative AI

Temasek's GenZero, an investor in South Pole, launches whitepaper addressing 'misconceptions' around carbon markets

Proxy advisor says vote FOR for all three resolutions at Manulife US REIT’s EGM 

Powell brushes off rate-cut bets as Fed moves carefully

Life on the road with  TUDOR pro cyclists Arvid de Kleijn, Sebastian Kolze Changizi and Maikel Zijlaard

Tennis pro Rafael Nadal’s fragrance line for Henry Jacques is now complete with the final addition of a solid perfume

A visit to the Jaeger-LeCoultre Manufacture offers insight into the artistry that goes into crafting a luxury timepiece

Watch out for three orphan companies

Why are we all freaking out about AI

The Bangkok jam is starting to clear

Hong Kong billionaire Cheng family's succession under spotlight

SATS gives notice of three years of consecutive losses

ByteDance fires hundreds, slashes games arm in major retreat

Manulife US REIT units fall over 40% on debt restructuring plans, DBS downgrades to 'hold'

'Is it time to revisit iFast?' UBS nearly doubles its target price to $10 on Hong Kong growth

Health officials 'visited' three of TalkMed's clinics concurrently to 'find out' use of cellular treatment

Related News

Highlights

MSCI boss warns of climate risks

Related News

TalkMed posts 18.5% increase in 2HFY2021 earnings to $14.3 mil

TalkMed Chonqing to set up internet hospitals in China through new joint venture company

TalkMed posts 20.7% rise in earnings to $11.6 mil on higher revenue